Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-26 @ 1:08 AM
Study NCT ID:
NCT02865434
Status:
COMPLETED
Last Update Posted:
2021-08-12
First Post:
2016-08-05
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RA
Sponsor:
Navidea Biopharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01
Start Date Type:
ACTUAL
Primary Completion Date:
2018-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-06
Completion Date Type:
ACTUAL
First Submit Date:
2016-08-05
First Submit QC Date:
None
Study First Post Date:
2016-08-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-09-15
Results First Submit QC Date:
None
Results First Post Date:
2021-08-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-08-11
Last Update Post Date:
2021-08-12
Last Update Post Date Type:
ACTUAL